Brief: Century Therapeutics Q2 Net Income USD -31.207 Million
08/08/2024 12:30
Aug 08 (Reuters) - Century Therapeutics Q2 basic EPS USD -0.38. * Q2 operating expenses USD 35.526 million * Q2 operating income USD -34.755 million * outlook FY operating expenses USD 150-160 million
Recent news on Century Therapeutics
See all newsCentury Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Century Therapeutics Q2 net loss misses estimates on lease termination loss
Brief: Century Therapeutics Q2 Net Income USD -34.55 Million Vs. IBES Estimate USD -22.4 Million
Century Therapeutics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
Century Therapeutics Inc expected to post a loss of 11 cents a share - Earnings Preview